Cargando…

Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

High engraftment rates are critical to any patient-derived xenograft (PDX) program and the loss of PDX models due to the development of lymphoproliferative tumors (LTs) is costly and inefficient. We hypothesized that routine injection of rituximab, an anti-CD20 antibody, at the time of implantation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leiting, Jennifer L., Hernandez, Matthew C., Yang, Lin, Bergquist, John R., Ivanics, Tommy, Graham, Rondell P., Truty, Mark J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459856/ https://www.ncbi.nlm.nih.gov/pubmed/30976061 http://dx.doi.org/10.1038/s41598-019-42470-w

Ejemplares similares

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment()
por: Hernandez, Matthew C., et al.
Publicado: (2018)

Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
por: Leiting, Jennifer L., et al.
Publicado: (2020)

Cancer “Avatars”: Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer
por: Lynch, Isaac T, et al.
Publicado: (2023)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()
por: Butler, Kristina A., et al.
Publicado: (2017)

Surgical Apgar Score for predicting patient outcome after hepatopancreaticobiliary surgeries
por: Nair, Abhijit S.
Publicado: (2018)

Professor Leslie H. Blumgart—Pioneering Hepatopancreaticobiliary Surgeon: a Tribute
por: Bhattacharya, Kaushik, et al.
Publicado: (2022)

Enhanced recovery after hepatopancreaticobiliary surgery: A single-center case control study
por: Nasir, Fakhar, et al.
Publicado: (2021)

Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom
por: Vaz, Osborne P, et al.
Publicado: (2021)

Pancreaticoduodenectomy with right hemicolectomy for advanced malignancy: a single UK hepatopancreaticobiliary centre experience
por: Das, Bibek, et al.
Publicado: (2022)

Negotiating the Curve of Laparoscopic Hepatopancreaticobiliary Procedures (Basic to Advanced) at a Tertiary Rural Teaching Institute
por: Kaushal-Deep, Singh Mathuria, et al.
Publicado: (2018)

EP1019: THE EFFECTS OF THE COVID-19 PANDEMIC ON PRESENTATIONS AND DIAGNOSIS OF UPPER GI AND HEPATOPANCREATICOBILIARY MALIGNANCIES
por: Carroll, Andrew, et al.
Publicado: (2022)

In vivo label-free optical signatures of chemotherapy response in human pancreatic ductal adenocarcinoma patient-derived xenografts
por: Park, Jaena, et al.
Publicado: (2023)

Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
por: Renuse, Santosh, et al.
Publicado: (2021)

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts()()
por: Corso, Simona, et al.
Publicado: (2018)

Rituximab Monotherapy in the Management of a Rare Case of an HIV Associated Lymphoproliferative Disorder
por: Hew, Jason, et al.
Publicado: (2017)

Post-transplantation lymphoproliferative disorder with gastrointestinal involvement
por: Inayat, Faisal, et al.
Publicado: (2018)

Transabdominal Ultrasonographic Findings of Gastrointestinal Lymphoproliferative Disease
por: Takahara, Masahiro, et al.
Publicado: (2019)

Receipt of Curative Resection or Palliative Care for Hepatopancreaticobiliary Tumours (RICOCHET): Protocol for a Nationwide Collaborative Observational Study
Publicado: (2019)

Early versus delayed reconstruction for bile duct injury a multicenter retrospective analysis of a hepatopancreaticobiliary group
por: Conde Monroy, Danny, et al.
Publicado: (2022)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
por: Pearce, David R., et al.
Publicado: (2023)

Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders
por: Karbasi-Afshar, R, et al.
Publicado: (2013)

Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach
por: Pizzi, Marco, et al.
Publicado: (2020)

Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial
por: O’Neill, Linda, et al.
Publicado: (2020)

Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size
por: Leiting, Jennifer L., et al.
Publicado: (2018)

Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
por: Hue, Susan Swee-Shan, et al.
Publicado: (2022)

Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract
por: Liu, Hailing, et al.
Publicado: (2023)

Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema
por: Kaur, Ravdeep, et al.
Publicado: (2014)

Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.
por: Nieto-Rios, John Fredy, et al.
Publicado: (2016)

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
por: Walti, Laura N., et al.
Publicado: (2020)

Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy
por: Sabbah, Mohamad, et al.
Publicado: (2021)

Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer
por: Bergquist, John R., et al.
Publicado: (2021)

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
por: Sicklick, Jason K, et al.
Publicado: (2014)

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract
por: Soderquist, Craig R., et al.
Publicado: (2020)

Embolization for acute gastrointestinal hemorrhage secondary to post-transplant lymphoproliferative disorder
por: Brahmbhatt, Akshaar N, et al.
Publicado: (2020)

Physiological and operative severity score for the enumeration of mortality and morbidity scoring systems for assessment of patient outcome and impact of surgeons’ and anesthesiologists’ performance in hepatopancreaticobiliary surgery
por: Fassoulaki, Argyro, et al.
Publicado: (2017)

Postoperative single-sequence (PoSSe) MRI: imaging work-up for CT-guided or endoscopic drainage indication of collections after hepatopancreaticobiliary surgery
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
por: Rai, Shinya, et al.
Publicado: (2018)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
por: Garner, Evan F., et al.
Publicado: (2018)

Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
por: Abdelrahman, Amro M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ggfvmpl203eu7s43r5k1n2qpfo